Yes-associated protein 65 (YAP65) has been implicated as an oncogene, and its expression is increased in human cancer. Previous studies have demonstrated that alterations in YAP activity may result in tumourigenesis of the prostate. With androgen deprivation therapies becoming progressively
ineffective, often leading to lifethreatening androgenresistant prostate cancer (CRPC). The present study aimed to analyse the role of YAP in prostate cancer (PCa), particularly in CRPC. YAP protein was detected using immunohistochemistry and western blot analysis in different prostatic tissues.
In addition, three specific RNA interference vectors targeting the human YAP gene were synthesised, and PC3 cells with a stable inhibition of YAP were obtained by transfection. MTT, flow cytometry, reverse transcriptionquantitative polymerase chain reaction and western blot assays were
used to analyse the effects of YAP inhibition on the proliferation and apoptosis of PC3 cells. The frequency of cells that were positive for YAP protein in PCa (78.13%) was significantly higher, compared with paraPCa (26.67%; P=0.007) and benign prostatic hyperplasia (0%; P=0.002). The frequency
of cells, which were positive for the expression of YAP exhibited a positive correlation (P=0.008) with the Gleason score, the tumournodemetastasis staging (P=0.033) and the level of prostate specific antigens (P=0.0032) in PCa. The proliferative capacity of the transfected group was significantly
lower, compared with the negative control group (P=0.022). The cellcycle of the transfected group was arrested in the G1 stage, which was detected using flow cytometry, and there was a significant increase in the apoptosis of cells in the transfected group (P=0.002). The mRNA and protein levels
of TEA domain family member 1 were inhibited in the transfected group (P=0.001 and P=0.00, respectively). Therefore, it was concluded that gene transcription and protein expression of YAP may be involved in the development of PCa, particularly CRPC, and may be a novel biomarker for investigation
of the occurrence and progression of CRPC. However, the mechanism underlying the modulation of YAP in CRPC remains to be fully elucidated.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Department of Urology, UniversityTown Hospital of Chongqing Medical University, Chongqing 401331, P.R. China
Department of Urology, Institute of Urology, First Hospital of Peking University, Beijing 100034, P.R. China
Department of Surgery, Life Science Research Institute of Chongqing Medical University, Chongqing 400016, P.R. China
October 1, 2015
More about this publication?
Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites